ESR2 and Behcet disease: Across these paradigms, selective activation of ER-β and GPR30 consistently modulates key pathophysiological domains relevant to BD—namely, neurotrophic support, inflammatory regulation, HPA axis responsivity, and monoaminergic homeostasis (9, 14, 35, 36).